Chatzigeorgiou, A., Seijkens, T., Zarzycka, B., Engel, D., Poggi, M., van den Berg, S., . . . Lutgens, E. (2014). Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. National Academy of Sciences.
Chicago-tyylinen lähdeviittausChatzigeorgiou, Antonios, et al. Blocking CD40-TRAF6 Signaling Is a Therapeutic Target in Obesity-associated Insulin Resistance. National Academy of Sciences, 2014.
MLA-viiteChatzigeorgiou, Antonios, et al. Blocking CD40-TRAF6 Signaling Is a Therapeutic Target in Obesity-associated Insulin Resistance. National Academy of Sciences, 2014.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.